PFM Health Sciences, LP - Q4 2020 holdings

$2.84 Billion is the total value of PFM Health Sciences, LP's 85 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 80.0% .

 Value Shares↓ Weighting
ALXN BuyALEXION PHARMACEUTICALS INC$153,292,000
+90.3%
981,131
+39.4%
5.39%
+44.8%
OM BuyOUTSET MED INC$150,608,000
+15.3%
2,911,207
+1.3%
5.30%
-12.3%
ABBV BuyABBVIE INC$99,309,000
+126.0%
926,823
+84.7%
3.49%
+71.9%
HZNP SellHORIZON THERAPEUTICS PUB L$97,202,000
-8.0%
1,328,803
-2.3%
3.42%
-30.0%
RCUS BuyARCUS BIOSCIENCES INC$87,575,000
+101.4%
3,373,460
+33.0%
3.08%
+53.2%
ARKG NewARK ETF TRput$83,934,000900,000
+100.0%
2.95%
ACAD BuyACADIA PHARMACEUTICALS INC$67,331,000
+287.6%
1,259,474
+199.1%
2.37%
+195.0%
IQV BuyIQVIA HLDGS INC$66,884,000
+25.5%
373,301
+10.4%
2.35%
-4.5%
UHS NewUNIVERSAL HLTH SVCS INCcl b$60,781,000442,044
+100.0%
2.14%
LLY NewLILLY ELI & CO$59,203,000350,645
+100.0%
2.08%
AVTR BuyAVANTOR INC$58,390,000
+104.4%
2,074,259
+63.3%
2.05%
+55.5%
ICUI SellICU MED INC$57,444,000
+3.7%
267,817
-11.6%
2.02%
-21.1%
MRNA BuyMODERNA INCput$56,414,000
+564.6%
540,000
+350.0%
1.98%
+405.1%
GILD SellGILEAD SCIENCES INC$54,862,000
-19.5%
941,674
-12.7%
1.93%
-38.7%
AZN BuyASTRAZENECA PLCsponsored adr$54,719,000
+157.4%
1,094,600
+182.2%
1.92%
+95.8%
NVRO SellNEVRO CORP$53,997,000
+21.8%
311,940
-2.0%
1.90%
-7.3%
MCK NewMCKESSON CORP$53,739,000308,987
+100.0%
1.89%
ANTM BuyANTHEM INC$52,735,000
+89.8%
164,238
+58.8%
1.86%
+44.4%
HCA SellHCA HEALTHCARE INC$51,556,000
+13.3%
313,487
-14.1%
1.81%
-13.8%
 AERIE PHARMACEUTICALS INCnote 1.500%10/0$47,987,000
+14.4%
51,850,0000.0%1.69%
-13.0%
ALXN NewALEXION PHARMACEUTICALS INCcall$46,872,000300,000
+100.0%
1.65%
MRTX SellMIRATI THERAPEUTICS INC$45,906,000
+11.0%
209,006
-16.1%
1.62%
-15.5%
EW  EDWARDS LIFESCIENCES CORP$44,506,000
+14.3%
487,8420.0%1.57%
-13.0%
 BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$43,210,000
+2.0%
40,300,0000.0%1.52%
-22.4%
NewNOVAVAX INCnote 3.750% 2/0$42,991,00034,000,000
+100.0%
1.51%
HRTX BuyHERON THERAPEUTICS INC$42,573,000
+53.5%
2,011,477
+7.5%
1.50%
+16.8%
IRTC BuyIRHYTHM TECHNOLOGIES INC$40,570,000
+2.0%
171,028
+2.4%
1.43%
-22.4%
THC BuyTENET HEALTHCARE CORP$39,372,000
+91.0%
986,019
+17.2%
1.38%
+45.3%
BIIB NewBIOGEN INCcall$39,178,000160,000
+100.0%
1.38%
DHR BuyDANAHER CORPORATION$38,042,000
+7.9%
171,252
+4.6%
1.34%
-17.9%
UNH NewUNITEDHEALTH GROUP INC$35,804,000102,099
+100.0%
1.26%
XLF NewSELECT SECTOR SPDR TRcall$35,025,0001,188,100
+100.0%
1.23%
PEN SellPENUMBRA INC$34,946,000
-24.9%
199,694
-16.6%
1.23%
-42.9%
BMRN BuyBIOMARIN PHARMACEUTICAL INCcall$32,594,000
+49.7%
371,700
+29.9%
1.15%
+13.9%
HUM  HUMANA INC$31,894,000
-0.9%
77,7400.0%1.12%
-24.6%
AERI  AERIE PHARMACEUTICALS INC$30,095,000
+14.8%
2,227,6110.0%1.06%
-12.6%
GH NewGUARDANT HEALTH INC$29,369,000227,876
+100.0%
1.03%
MYOV BuyMYOVANT SCIENCES LTD$28,896,000
+227.4%
1,046,212
+66.5%
1.02%
+149.3%
BIIB BuyBIOGEN INC$28,062,000
+10.3%
114,604
+27.7%
0.99%
-16.1%
BMY NewBRISTOL-MYERS SQUIBB CO$27,993,000451,275
+100.0%
0.98%
BMRN SellBIOMARIN PHARMACEUTICAL INC$27,578,000
-48.2%
314,499
-55.1%
0.97%
-60.6%
HSIC SellHENRY SCHEIN INC$26,420,000
+11.7%
395,161
-1.8%
0.93%
-15.0%
LH SellLABORATORY CORP AMER HLDGS$26,075,000
-3.4%
128,100
-10.6%
0.92%
-26.5%
PPD SellPPD INC$25,421,000
-12.8%
742,863
-5.7%
0.89%
-33.7%
PFE BuyPFIZER INC$25,219,000
+43.6%
685,125
+43.2%
0.89%
+9.2%
NVAX NewNOVAVAX INC$24,076,000215,908
+100.0%
0.85%
TCRR  TCR2 THERAPEUTICS INC$23,995,000
+52.2%
775,7940.0%0.84%
+15.8%
ICLR  ICON PLC$23,656,000
+2.0%
121,3230.0%0.83%
-22.4%
WAT NewWATERS CORP$23,380,00094,497
+100.0%
0.82%
IOVA NewIOVANCE BIOTHERAPEUTICS INCput$23,200,000500,000
+100.0%
0.82%
JWS NewJAWS ACQUISITION CORP$22,389,0001,669,565
+100.0%
0.79%
MOH SellMOLINA HEALTHCARE INC$21,674,000
-27.1%
101,907
-37.3%
0.76%
-44.6%
LUNG NewPULMONX CORP$20,260,000302,631
+100.0%
0.71%
CYTK NewCYTOKINETICS INC$20,181,000971,151
+100.0%
0.71%
CNC NewCENTENE CORP DEL$19,719,000328,479
+100.0%
0.69%
NVAX NewNOVAVAX INCcall$16,727,000150,000
+100.0%
0.59%
STTK NewSHATTUCK LABS INC$16,202,000386,813
+100.0%
0.57%
ATHA BuyATHIRA PHARMA INC$16,105,000
+122.3%
470,227
+19.8%
0.57%
+69.3%
HZNP NewHORIZON THERAPEUTICS PUB Lcall$15,939,000217,900
+100.0%
0.56%
IONS NewIONIS PHARMACEUTICALS INC$14,893,000263,412
+100.0%
0.52%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$14,525,000
+114.3%
2,694,769
+217.2%
0.51%
+63.3%
ZLAB NewZAI LAB LTDadr$14,490,000107,061
+100.0%
0.51%
ACAD NewACADIA PHARMACEUTICALS INCcall$14,434,000270,000
+100.0%
0.51%
KNTE NewKINNATE BIOPHARMA INC$13,601,000341,905
+100.0%
0.48%
CNST SellCONSTELLATION PHARMCETICLS I$13,526,000
-48.4%
469,664
-63.7%
0.48%
-60.8%
DVAX  DYNAVAX TECHNOLOGIES CORP$13,070,000
+3.0%
2,936,9900.0%0.46%
-21.6%
SPRB NewSPRUCE BIOSCIENCES INC$12,868,000529,311
+100.0%
0.45%
MYOV NewMYOVANT SCIENCES LTDcall$11,366,000411,500
+100.0%
0.40%
MRTX SellMIRATI THERAPEUTICS INCcall$9,730,000
-62.7%
44,300
-71.8%
0.34%
-71.6%
SellTRILLIUM THERAPEUTICS INC$8,813,000
-44.9%
599,111
-46.8%
0.31%
-58.1%
SBTX NewSILVERBACK THERAPEUTICS INC$8,723,000188,243
+100.0%
0.31%
PACB NewPACIFIC BIOSCIENCES CALIF INput$8,301,000320,000
+100.0%
0.29%
RVMD SellREVOLUTION MEDICINES INC$8,279,000
-34.0%
209,116
-42.0%
0.29%
-49.8%
CERT NewCERTARA INC$7,688,000228,000
+100.0%
0.27%
FLDM  FLUIDIGM CORP DEL$6,338,000
-19.3%
1,056,3430.0%0.22%
-38.6%
CRSP NewCRISPR THERAPEUTICS AGput$6,278,00041,000
+100.0%
0.22%
RCUS SellARCUS BIOSCIENCES INCcall$6,160,000
+49.7%
237,300
-1.1%
0.22%
+14.2%
BLSA NewBCLS ACQUISITION CORP$5,513,000500,000
+100.0%
0.19%
JYAC NewJIYA ACQUISITION CORP$5,150,000500,000
+100.0%
0.18%
OSH NewOAK STR HEALTH INC$4,431,00072,451
+100.0%
0.16%
 NEVRO CORPnote 2.750% 4/0$3,666,000
+16.3%
2,000,0000.0%0.13%
-11.6%
AMWL  AMERICAN WELL CORPcl a$3,293,000
-14.5%
130,0000.0%0.12%
-34.8%
EDIT NewEDITAS MEDICINE INC$2,096,00029,900
+100.0%
0.07%
 ACORDA THERAPEUTICS INCnote 1.750% 6/1$1,000,000
-16.7%
2,000,0000.0%0.04%
-36.4%
ALNA  ALLENA PHARMACEUTICALS INC$364,000
-13.5%
284,2850.0%0.01%
-31.6%
ZEN ExitZENDESK INC$0-67,034
-100.0%
-0.32%
ST ExitSENSATA TECHNOLOGIES HLDNG P$0-193,585
-100.0%
-0.39%
ALLO ExitALLOGENE THERAPEUTICS INC$0-224,266
-100.0%
-0.39%
V ExitVISA INC$0-43,468
-100.0%
-0.40%
SHOP ExitSHOPIFY INCcl a$0-9,454
-100.0%
-0.45%
ITOS ExitITEOS THERAPEUTICS INC$0-406,467
-100.0%
-0.46%
KRTX ExitKARUNA THERAPEUTICS INC$0-137,960
-100.0%
-0.49%
RNA ExitAVIDITY BIOSCIENCES, INC.$0-441,155
-100.0%
-0.51%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-381,990
-100.0%
-0.58%
NEE ExitNEXTERA ENERGY INC$0-47,151
-100.0%
-0.60%
APTV ExitAPTIV PLC$0-150,794
-100.0%
-0.64%
NVDA ExitNVIDIA CORPORATION$0-25,911
-100.0%
-0.65%
AMZN ExitAMAZON COM INC$0-5,342
-100.0%
-0.78%
DE ExitDEERE & CO$0-76,336
-100.0%
-0.78%
NXPI ExitNXP SEMICONDUCTORS N V$0-144,881
-100.0%
-0.84%
HOLX ExitHOLOGIC INC$0-272,193
-100.0%
-0.84%
PKI ExitPERKINELMER INC$0-147,000
-100.0%
-0.85%
MSFT ExitMICROSOFT CORP$0-95,177
-100.0%
-0.93%
GILD ExitGILEAD SCIENCES INCcall$0-350,000
-100.0%
-1.02%
XBI ExitSPDR SER TRput$0-200,000
-100.0%
-1.03%
MRK ExitMERCK & CO. INCcall$0-340,000
-100.0%
-1.30%
SQ ExitSQUARE INCcl a$0-181,509
-100.0%
-1.36%
PFE ExitPFIZER INCcall$0-926,000
-100.0%
-1.57%
QQQ ExitINVESCO QQQ TRput$0-381,500
-100.0%
-4.90%
IMMU ExitIMMUNOMEDICS INC$0-1,343,570
-100.0%
-5.28%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-02-19
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC41Q3 20232.2%
HCA HOLDINGS INC38Q3 20235.2%
HUMANA INC37Q3 20233.8%
EDWARDS LIFESCIENCES CORP36Q3 20233.3%
UNITEDHEALTH GROUP INC33Q3 20234.8%
PENUMBRA INC33Q3 20234.8%
AERIE PHARMACEUTICALS INC28Q2 20223.7%
TENET HEALTHCARE CORP27Q3 20232.3%
ELEVANCE HEALTH INC26Q3 20234.2%
ICON PLC26Q3 20232.5%

View PFM Health Sciences, LP's complete holdings history.

Latest significant ownerships (13-D/G)

View PFM Health Sciences, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-21

View PFM Health Sciences, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export PFM Health Sciences, LP's holdings